BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 24459642)

  • 21. Hepatitis C virus infection-associated markers in sera from blood donors in Surabaya, Indonesia.
    Darmadi S; Soetjipto ; Handajani R; Lusida MI; Soemarto ; Sakugawa H; Ishido S; Hotta H
    Microbiol Immunol; 1996; 40(5):401-5. PubMed ID: 8805106
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prevalence, risk factors, and genotype distribution of hepatitis C virus infection in the general population: a community-based survey in southern Italy.
    Guadagnino V; Stroffolini T; Rapicetta M; Costantino A; Kondili LA; Menniti-Ippolito F; Caroleo B; Costa C; Griffo G; Loiacono L; Pisani V; Focà A; Piazza M
    Hepatology; 1997 Oct; 26(4):1006-11. PubMed ID: 9328327
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Quantitative assessment of hepatitis C virus RNA and IgM antibodies to hepatitis C core in chronic hepatitis C.
    Martinelli AL; Brown D; Braun HB; Michel G; Dusheiko GM
    J Hepatol; 1996 Jan; 24(1):21-6. PubMed ID: 8834020
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Threshold value of the anti-HCV test in the diagnosis of HCV infection.
    Kirişci Ö; Calıskan A
    J Infect Dev Ctries; 2019 Oct; 13(10):914-919. PubMed ID: 32084022
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hepatitis C virus viremia and low platelet count: a study in a hepatitis B & C endemic area in Taiwan.
    Dai CY; Ho CK; Huang JF; Hsieh MY; Hou NJ; Lin ZY; Chen SC; Hsieh MY; Wang LY; Chang WY; Yu ML; Chuang WL
    J Hepatol; 2010 Feb; 52(2):160-6. PubMed ID: 20034694
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Determination of the cut-off value of serum alanine aminotransferase in patients undergoing hemodialysis, to identify biochemical activity in patients with hepatitis C viremia.
    Lopes EP; Gouveia EC; Albuquerque AC; Sette LH; Mello LA; Moreira RC; Coelho MR
    J Clin Virol; 2006 Mar; 35(3):298-302. PubMed ID: 16290052
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Relationship between hepatitis C virus infection and schistosomal liver disease: not simply an additive effect.
    Gad A; Tanaka E; Orii K; Rokuhara A; Nooman Z; Serwah AH; Shoair M; Yoshizawa K; Kiyosawa K
    J Gastroenterol; 2001 Nov; 36(11):753-8. PubMed ID: 11757747
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hepatitis C virus (HCV)-specific in vitro antibody secretion by peripheral blood lymphocytes: correlation with progression of disease and HCV RNA in HCV antibody-positive patients.
    Ducos J; Bianchi-Mondain AM; Francois M; Boisset M; Vendrell JP; Barin F; Serre A; Larrey D
    J Clin Microbiol; 1994 Oct; 32(10):2613-5. PubMed ID: 7529245
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Significance of anti-HCV signal-to-cutoff ratio in predicting hepatitis C viremia.
    Seo YS; Jung ES; Kim JH; Jung YK; Kim JH; An H; Yim HJ; Yeon JE; Byun KS; Kim CD; Ryu HS; Um SH
    Korean J Intern Med; 2009 Dec; 24(4):302-8. PubMed ID: 19949727
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Low positive anti-HCV microparticle enzyme immunoassay results: do they predict hepatitis C virus infection?].
    Sayan M; Meriç M; Mutlu B; Celebi S; Willke A
    Mikrobiyol Bul; 2006; 40(1-2):81-4. PubMed ID: 16775961
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Positive predictability and predictive factors of the third generation anti-hepatitis C virus (HCV) ELISA test for HCV infection].
    Kim YK; Kim BH; Jin ES; Nam KD; Jang JY; Kim NH; Lee SK; Joo KR; Dong SH; Kim HJ; Chang YW; Lee JI; Chang R
    Korean J Gastroenterol; 2005 Mar; 45(3):181-8. PubMed ID: 15778545
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Detection of hepatitis C virus (HCV) RNA in the liver of healthy, anti-HCV antibody-positive, serum HCV RNA-negative patients with normal alanine aminotransferase levels.
    Carreño V; Pardo M; López-Alcorocho JM; Rodríguez-Iñigo E; Bartolomé J; Castillo I
    J Infect Dis; 2006 Jul; 194(1):53-60. PubMed ID: 16741882
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Guideline for interpretation and report of the antibody to hepatitis C virus. Grupo de Desarrollo de la Guía ].
    Contreras AM; Ochoa-Jiménez RJ; Kershenobich D; Granados-García V; Conde-González CJ; Celis A; Pérez-Gómez HR; Ruelas-Hernández S; Romero-Flores P; Alcántar-Luna E; Sierra-García de Quevedo J; Ancona-Pisté O;
    Rev Invest Clin; 2012; 64(6 Pt 2):641-78. PubMed ID: 23593783
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluation of an enzyme immunoassay for hepatitis C virus antibody detection using a recombinant protein derived from the core region of hepatitis C virus genome.
    Lopes EP; Granato CH; Lanzoni V; Granero L; Paranhos-Baccala G; Tomiyama H; Silva AE; Ferraz ML
    Mem Inst Oswaldo Cruz; 2000; 95(5):717-20. PubMed ID: 10998223
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Non-specific and specific anti-HCV results correlated to age, sex, transaminase, rhesus blood group and follow-up in blood donors.
    Caspari G; Gerlich WH; Beyer J; Schmitt H
    Arch Virol; 1997; 142(3):473-89. PubMed ID: 9349294
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Usefulness of the hepatitis C virus core antigen assay for screening of a population undergoing routine medical checkup.
    Gaudy C; Thevenas C; Tichet J; Mariotte N; Goudeau A; Dubois F
    J Clin Microbiol; 2005 Apr; 43(4):1722-6. PubMed ID: 15814991
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A potential new way to facilitate HCV elimination: The prediction of viremia in anti-HCV seropositive patients using machine learning algorithms.
    Bal T; Dirican E
    Arab J Gastroenterol; 2024 May; 25(2):223-229. PubMed ID: 38705815
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hepatitis C virus infection in Spanish volunteer blood donors: HCV RNA analysis and liver disease.
    Muñoz-Gómez R; García-Monzón C; García-Buey L; Lo Iacono O; Borque MJ; Garía-Sánchez A; Pajares JM; Moreno-Otero R
    Eur J Gastroenterol Hepatol; 1996 Mar; 8(3):273-7. PubMed ID: 8724030
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [A preliminary assessment of the clinical utility of measuring hepatitis C virus antibody to evaluate infection status].
    Long L; Liu Y; Duan Z; Xu Q; Shen T; Dou X; Zhuang H; Lu F
    Zhonghua Gan Zang Bing Za Zhi; 2014 Apr; 22(4):244-50. PubMed ID: 25173220
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Low-positive anti-hepatitis C virus enzyme immunoassay results: an important predictor of low likelihood of hepatitis C infection.
    Dufour DR; Talastas M; Fernandez MD; Harris B; Strader DB; Seeff LB
    Clin Chem; 2003 Mar; 49(3):479-86. PubMed ID: 12600961
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.